CXCR3 Ligands: Redundant, Collaborative and Antagonistic Functions
Overview
Cell Biology
Authors
Affiliations
CXCR3 is a chemokine receptor that is rapidly induced on naïve T cells following activation, and preferentially remains highly expressed on type-1 helper (Th1)-type CD4(+) T cells, effector CD8(+) T cells and innate-type lymphocytes, such as natural killer (NK) and NKT cells. CXCR3 is activated by three interferon (IFN)-γ-inducible ligands CXCL9 (monokine induced by gamma-interferon), CXCL10 (interferon-induced protein-10) and CXCL11 (interferon-inducible T-cell alpha chemoattractant). Although some studies have revealed that these ligands have redundant functions in vivo, other studies have demonstrated that the three CXCR3 ligands can also collaborate and even compete with each other. Differential regulation of the three ligands at specific times in defined anatomically restricted locations in vivo likely participates in the fine control of T-cell trafficking over the course of an immune response. Among the differences in regulation, CXCL10 is induced by a variety of innate stimuli that induce IFN-α/β as well as the adaptive immune cell cytokine IFN-γ, whereas CXCL9 induction is restricted to IFN-γ. In this review, we will discuss how the balance, timing and pattern of CXCR3 ligand expression appears to regulate the generation of effector T cells in the lymphoid compartment and subsequent migration into peripheral sites of Th1-type inflammation in which the CXCR3 ligands also then regulate the interactions and migratory behavior of effector T cells in an inflamed peripheral tissue.
Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection.
Broomfield B, Tan C, Qin R, Abberger H, Duckworth B, Alvarado C J Exp Med. 2025; 222(5).
PMID: 40062995 PMC: 11893171. DOI: 10.1084/jem.20241148.
Pathophysiology of Alopecia Areata in the Pediatric Patient.
Fitzhugh M, Hansen J, Jabbari A, Berrebi K Pediatr Dermatol. 2025; 42 Suppl 1:24-30.
PMID: 40044623 PMC: 11882487. DOI: 10.1111/pde.15842.
Candidate approaches for predicting vitiligo recurrence: an effective model and biomarkers.
Liu B, Shen J, Li J, Tian B, Zhou B, Gui J Front Immunol. 2025; 16:1468665.
PMID: 39981245 PMC: 11839629. DOI: 10.3389/fimmu.2025.1468665.
Sex-specific differences in primary Sjögren's disease.
Punnanitinont A, Kramer J Front Dent Med. 2025; 4:1168645.
PMID: 39916928 PMC: 11797869. DOI: 10.3389/fdmed.2023.1168645.
Role of CXCL10 released from osteocytes in response to TNF-α stimulation on osteoclasts.
Miura M, Kitaura H, Ohori F, Narita K, Ren J, Noguchi T Sci Rep. 2025; 15(1):3040.
PMID: 39856227 PMC: 11760356. DOI: 10.1038/s41598-025-87092-7.